Normand F. Smith

Biography

Normand Smith is a partner at Burns and Levinson, Boston, Massachusetts. Prior to joining Burns & Levinson in January 2006, Mr. Smith was a Partner at the firm Perkins Smith & Cohen LLP. Mr. Smith received his J.D. and LL.M, from Boston University Law School and did his undergraduate work at Hamilton College. Mr. Smith has been admitted by the Bar in Massachusetts, New York, U.S. Tax Court and the U.S. Court of Appeals. In his law practice, Mr. Smith has served as counsel to individual entrepreneurs and scientists in the areas of personal tax planning and the formation and management of businesses, primarily in the high tech and biotech areas. He also served as general counsel to businesses, primarily in the high tech and biotech areas and to not for profit institutions workings in the United States and internationally. Additionally, Mr. Smith has served as counsel to individuals accused of scientific misconduct, including representation before university tribunals, Health and Human Services, the National Institute of Health and the United States Congress. In 2006, Normand Smith was selected as Massachusetts Super Lawyer. The selection of attorneys is based on a poll and internal research done by Law & Politics Magazine and reviewed by an independent blue ribbon panel of their peers. Listed attorneys and finalists consist of the top 5% of attorneys in Massachusetts. The listing appeared in the November issue of Boston Magazine and in New England Super Lawyers Magazine. Mr. Smith is a member of the Boston Bar Association, Massachusetts Bar Association, New York Bar Association, Board Member (gubernatorial appointee) of the Industrial Services Program, a quasi public state agency committed to helping small and medium sized businesses become active players in world markets while keeping jobs and revenues in Massachusetts, Board Member and former Chair of the Pathfinder International, a not for profit organization directing in excess of $50 million of private and United States government funds to family planning projects in thirty (30) developing countries, former Chair of the Boston Zoological Society and The Society for the Preservation of New England Antiquities. Mr. Smith also currently serves on boards of various other for profit organizations. 

Research Interest

Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform the field of regenerative medicine.